Voyager Therapeutics, Inc. Gains 44.53%
Fri, Oct 08, 2021 at 05:33 PM
Voyager Therapeutics, Inc. (VYGR:NASDAQ) shot up at $5.55, a gain of 44.5%. On Thu, Oct 07, 2021, VYGR:NASDAQ hit a New 2-Week Intraday High of $3.97. The stock appeared on our News Catalysts scanner on Thu, Oct 07, 2021 at 01:51 PM in the 'AGREEMENT' category. From Thu, Sep 23, 2021, the stock recorded 30.00% Up Days and 18.18% Green Days
The stock spiked on Mon, Apr 26, 2021 at $5.97 with a volume of 7M+.
About Voyager Therapeutics, Inc. (VYGR:NASDAQ)
Voyager Therapeutics Inc, in collaboration with Genzyme, conducts research and development work to develop therapies for the treatment of central nervous system disorders. It targets diseases such as Parkinson's, Alzheimer's Huntington's.
Top 10 Gainers:
- ChemoCentryx, Inc. (CCXI:NASDAQ), 95.97%
- DATS (DATS:NASDAQ), 45.77%
- Voyager Therapeutics, Inc. (VYGR:NASDAQ), 44.53%
- Renren Inc. (RENN:NYSE), 44.46%
- HUDI (HUDI:NASDAQ), 36.27%
- ORIC Pharmaceuticals, Inc. (ORIC:NASDAQ), 25.9%
- NXTP (NXTP:NASDAQ), 23.68%
- MITC (MITC:NASDAQ), 21.98%
- Altisource Portfolio Solutions S.A. (ASPS:NASDAQ), 21.19%
- Aehr Test Systems (AEHR:NASDAQ), 16.69%